Brett Sandercock serves as the Chief Financial Officer (CFO) at ResMed Inc., a global leader in the development and manufacturing of medical equipment for the treatment of sleep-disordered breathing and other respiratory conditions. In his role as CFO, Sandercock is responsible for overseeing the company's financial operations, including financial planning and analysis, accounting, tax, treasury, and investor relations. His strategic vision and financial acumen have been instrumental in guiding ResMed through periods of significant growth and expansion. Prior to joining ResMed in 2004, Sandercock held various senior financial positions at leading multinational corporations. He began his career at Ernst & Young, where he honed his skills in auditing and financial management. Sandercock's extensive experience in the healthcare and technology sectors has been a valuable asset to ResMed, enabling the company to navigate complex financial landscapes and maintain its position as an industry leader. Under his leadership, ResMed has consistently delivered strong financial performance and has been recognized for its commitment to innovation and patient care. Throughout his tenure at ResMed, Sandercock has played a key role in driving the company's strategic initiatives, including the expansion of its product portfolio and the development of new markets. His leadership has been pivotal in the successful integration of acquisitions and the implementation of cost-saving measures that have strengthened ResMed's financial position. Sandercock's dedication to fostering a culture of transparency and accountability has earned him the respect of his colleagues and the trust of investors, solidifying his reputation as a visionary leader in the healthcare industry.